Miejsce:
Online
Data:
07.10 - 09.10 / 2021

14th International Cardiovascular Reasearch Meeting

Konferencja pod patronatem Oddziału Bydgoskiego Polskiego Towarzystwa Kardiologicznego

Transmisja Live

Szanowni Państwo!

Dziękujemy za obecność.

Konferencja odbyła się w dniach 7-9 października 2021 r.

PROGRAM MERYTORYCZNY

Zapraszamy do zapoznania się ze szczegółami programu.

09:15 - 09:20
Opening speech

Jacek Kubica

09:20 - 09:40
Coronary revascularization plus medical therapy or medical therapy alone in elective patients with chronic coronary syndrome (Lecture of the day)

Eliano P. Navarese

09:40 - 09:45
Break
09:45 - 11:00
SESSION 1
09:45 - 10:00
Reduced hospital admissions and increased mortality for acute Heart Failure during COVID-19 pandemic in Poland: a multicentre study (HF-COV-SIRIO 6 study)

Małgorzata Ostrowska

10:00 - 10:15
Predictors of in-hospital clinical outcome in COVID-19 patients

Klaudyna Grzelakowska

10:15 - 10:30
Determinants of anti-SARS-CoV-2 antibodies after vaccination

Magdalena Krintus

10:30 - 10:45
IMPACT of PCSK9 inhibition on clinical outcome in patients during the inflammatory stage of the COVID-19 (The IMPACT COVID 19 - SIRIO 5 randomized study)

Jacek Kubica

10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 2
11:15 - 11:30
Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines

Marco Cattaneo

11:30 - 11:45
Optimal Antithrombotic treatment in COVID-19 Patients

Giuseppe Patti

11:45 - 12:00
Biomarkers of Thrombosis in COVID-19

Diana Gorog

12:00 - 12:15
Aspirin as an Ideal Pharmacologic Therapy for COVID-19

Udaya Tantry

12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 3
12:45 - 13:00
Inhaled Acetylsalicylic Acid for Immediate Platelet Inhibition

Paul A. Gurbel

13:00 - 13:15
Ethnic difference of thrombogenicity in patients with coronary artery disease

Young-Hoon Jeong

13:15 - 13:30
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention

Jolanta Siller-Matula

13:30 - 13:45
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

Andrzej Budaj

13:45 - 14:00
Mortality risk prediction in patients with cardiogenic shock (The CardShock study)

Salvatore di Somma

14:00 - 14:15
DISCUSSION
14:15 - 16:15
SESSION 4 - ELECTRA trial investigators meeting
09:00 - 09:20
PCSK9 vaccine – a future therapeutic option or illusory hopes (Lecture of the day)

Maciej Banach

09:20 - 09:30
Break
09:30 - 11:00
SESSION 6
09:30 - 09:45
Acute coronary syndromes in elderly patients

Stefano De Servi

09:45 - 10:00
Cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction (The COOL AMI EU Pivotal Trial)

Marko Noc

10:00 - 10:15
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention (The TWILIGHT Trial)

Robert Gil

10:15 - 10:30
Resorbable Magnesium Scaffold in ACS patients

Magdalena Łanocha

10:30 - 10:45
Baseline electrocardiographic predictors of Left Ventricular Remodeling in STEMI

Tomasz Fabiszak

10:45 - 11:00
DISCUSSION
11:00 - 11:15
Break
11:15 - 12:30
SESSION 7
11:15 - 11:30
Rivaroxaban in Peripheral Artery Disease (The VOYAGER PAD Trial)

Marc Bonaca

11:30 - 11:45
Venous Thromboembolism in cancer patients

Adam Torbicki

wykład sponsorowany przez firme Pfizer

11:45 - 12:00
Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy

Klemen Steblovnik

12:00 - 12:15
Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model

Leszek Gromadziński

12:15 - 12:30
DISCUSSION
12:30 - 12:45
Break
12:45 - 14:15
SESSION 8
12:45 - 13:00
NCU-AF: on-line qualification for ablation of atrial fibrillation and left atrial appendage occlusion

Piotr Adamski

13:00 - 13:15
Management of patients with coronary artery disease in Lithuania

Jolita Badariene

13:15 - 13:30
Outcomes of managed care in acute myocardial infarction survivors survivors

Piotr Jankowski

13:30 - 13:45
Determinants of elevated lipid parameters in patients without diagnosed car-diovascular disease - results from the polish arm of the EUROASPIRE V sur-vey

Jakub Ratajczak

13:45 - 14:00
PCSK9 inhibitors in acute coronary syndrome

Miłosz Jaguszewski

14:00 - 14:15
DISCUSSION
14:15 - 14:30
Break
14:30 - 15:45
SESSION 9
14:30 - 14:45
Impact of COVID-19 on clinical outcome in acute coronary syndrome patients

Wojciech Wojakowski

14:45 - 15:00
Renal injury in patients admitted due to Covid-19 – single centre experience

Małgorzata Jasiewicz

15:00 - 15:15
Electrotherapy in the COVID-19 era in Poland

Jarosław Kaźmierczak

15:15 - 15:30
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors

Marek Postuła

15:30 - 15:45
DISCUSSION
15:45 - 17:00
SIRIO MEDICINE network meeting
09:00 - 09:20
On the Shades of Coronary Calcium and Plaque Instability - (Lecture of the day)

Eloisa Arbustini

09:20 - 09:30
Break
09:30 - 11:00
SESSION 11
09:30 - 09:45
Levosimendan improves the acute course of takotsubo syndrome

Miłosz Jaguszewski

09:45 - 10:00
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Fail-ure and Reduced Ejection Fraction

Jarosław Drożdż

10:00 - 10:15
Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock (CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry)

Przemysław Trzeciak

10:15 - 10:30
Long-term outcomes following drug-eluting balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis (DEB-Dragon-Registry)

Piotr Niezgoda

10:30 - 10:45
The impact of the COVID-19 pandemic on the functioning of the emergency medical service

Michał Kasprzak

10:45 - 11:00
DISCUSSION
11:00 - 11:15
Closing remarks

Jacek Kubica

Kontakt

Kontakt w sprawie
Problemów Technicznych
Krzysztof Sęk

Organizatorem logistycznym konferencji jest Grupa Gran
ul. Generała Tadeusza Bora-Komorowskiego 35, 85-793 Bydgoszcz